Virtus Biotech Clinical Trials ETF BBC
40.73 USD -2.89 (-6.63%)
At closeNov 5, 2026, 4:00 PM EST
40.73 0.00 0.00%
After hours · Nov 5, 4:00 PM ET
40.70 Day range 42.45
28.73 52-week range 56.18
- YTD
- +5.63%
- 1 year
- +35.99%
- Market cap
- 32.59M
- YTD return
- +5.63%
- 1-year return
- +35.99%
- Volume
- 78.73K
- Avg volume
- 29.35K
- Open
- 43.43
- Previous close
- 43.62
- Day's range
- 40.70 – 42.45
- 52-week range
- 28.73 – 56.18
6M -5.29 (-11.50%)
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 27.91
- 200-day average
- 27.48
About Virtus Biotech Clinical Trials ETF
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on BBC — it syncs with the Stock Master app.